Immunome Sales Trigger Battle Card

Max Rosett greenlit 117k stock options under Nasdaq Rule 5635(c)(4). Strike on equity admin pain. Pitch compliance & onboarding to open pipeline and close fast. 🔥

Published on


Do not index
Do not index

🚀 Battle Card: Immunome, Inc.

Quick trigger:
 
👤 Decision Maker in the News
 
💡 Why It Matters
  • Granting 117,000 stock options to eight new hires under Nasdaq inducement rules accelerates talent acquisition but spikes equity-plan complexity → Source. Leverage this Immunome, Inc. sales trigger to win the first call.
 
🎯 Core Pain Point
  • Equity-plan administration complexity
  • Onboarding & retention of key biotech talent
 
💰 What to Pitch
  • Primary: Equity management platform → centralized grant administration and Nasdaq 5635(c)(4) compliance to capitalize on the current Immunome, Inc. sales trigger
  • Expansion: Employee onboarding suite → streamlined new-hire integration and retention
 
🗺️ Quick Context
  • HQ: Bothell, WA
  • Employees: ≈ 100
  • Rev: ≈ $0M
 

🤼 Competitive Intel

*Which other vendors you’ll probably face to win **Immunome, Inc.*’s business.
 
  • CartaEquity Management
    • Unique edge: Integrated cap table + compliance
    • Evaluated by CFO for streamlined grants
  • ShareworksEquity Management
    • Unique edge: Scalable for biotech IPO readiness
    • Evaluated by Compensation Committee for Nasdaq compliance
  • CertentEquity Management
    • Unique edge: Advanced reporting & audit trails
    • Evaluated by Finance for audit readiness
  • BambooHRHRIS / Onboarding
    • Unique edge: User-friendly workflows
    • Evaluated by HR for new-hire integration
  • GreenhouseRecruiting / Onboarding
    • Unique edge: Talent pipeline visibility
    • Evaluated by Talent Acquisition for faster hiring
 

✅ Do-Now Checklist

Connect with all decision makers on LinkedIn (links above)
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
 

Next Step

Get intel like this daily—no fluff, all pipeline. Subscribe to NewsletterForLeads Don’t miss the next Immunome, Inc. sales trigger.
 

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑<your company>❑
OFFER_BRIEF   = ❑Centralized equity management for seamless Nasdaq compliance❑
PROOF_METRIC  = ❑Reduced grant admin time by 40%❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = ≈ TBD
COMPANY     = Immunome, Inc.
DEPT        = HR
SIZE        = 8
BOTTLENECK  = Equity-plan administration complexity
EVENT       = Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DETAIL      = Granted inducement awards of 117,000 stock options to 8 new employees
PAIN        = Onboarding & retention of key biotech talent
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250904636814&div=41152219
SIM_CO      = Seattle Genetics
WIN_METRIC  = 40% time savings
NEXT_SIZE   = ≈ 15
EMP_EST     = ≈ 100
REV_EST     = ≈ $0M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: 8-person HR

≈ TBD—noticed your HR team is ≈ 8.

That’s when Equity-plan administration complexity slows growth.

We helped Seattle Genetics fix this with Centralized equity management for seamless Nasdaq compliance.

Result: 40% time savings.  
Quick call?

PS—next bottleneck hits ≈ 15.

DM ≤45 words, TONE:
Saw your post about Granted inducement awards of 117,000 stock options to 8 new employees — Onboarding & retention of key biotech talent.  
Centralized equity management for seamless Nasdaq compliance. Reduced grant admin time by 40%.  
Quick chat?

Join other 3200+ marketers now!

Ready to take the next big step for your business?

Subscribe